Arno Therapeutics, Inc. (ARNI/ARNI.OB) Wrap Up:

Arno Therapeutics, Inc., a development-stage company, engages in developing and commercializing products for the treatment of cancer. The company’s lead compound, AR-67, is a Phase I clinical trial novel anti-cancer agent. It also develops AR-12 and AR-42, which are preclinical stage oncology products. The company is based in the Fairfield, New Jersey.

otc, otcbb, pinksheet, ARNI, ob Arno Therapeutics, Inc.

More Recent News About Arno Therapeutics, Inc.

Would you like to leave a comment about Arno Therapeutics, Inc. ARNI/ARNI.OB

Submit

Find out what social network information about Arno Therapeutics, Inc. are available on Realpennies Worst 5 - Click here to find out what stocks have been voted down by our visitors and users

Besides Arno Therapeutics, Inc. there is more great information available at Realpennies.com

Copyright © 2009, RealPennies.com
RealPennies.com is not a registered investment advisor and quotes are delayed.
All information here is for informational purposes only, not intended for trading purposes or advice. By accessing this site, you have viewed and agree to our disclaimer.